#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Subdural haematoma Squamous cell carcinoma of the oral cavity Pseudoxanthoma elasticum Leiomyosarcoma recurrent Epilepsy Glioma Phenylketonuria Angiosarcoma Graft versus host disease Extra-osseous Ewing's sarcoma metastatic Hypergammaglobulinaemia benign monoclonal Fusarium infection Follicular lymphoma stage III Lung adenocarcinoma Chemical burn More trials…

    Learn about Rare Diseases

    Osteosarcoma Wiskott-Aldrich syndrome – Diagnostics KBG syndrome – Basic Information Rhabdomyosarcoma recurrent – Diagnostics Synovial sarcoma recurrent – Life with Disease Lymphangiosarcoma – Treatment Breast angiosarcoma metastatic – Life with Disease Alternating hemiplegia of childhood Myelodysplastic syndrome – Trials in Disease Antithrombin III deficiency – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gfh925 Vitamin A Bp Aup1602-C Alendronate Sodium Monohydrate Bexotegrast Specific Nucleic Acid Sna-Ebv Fenebrutinib Balcinrenone BW-20805 Acasunlimab Enoxaparin Sodium Cimetidine ARFOLITIXORIN Elamipretide Trihydrochloride Adagrasib Demeclocycline Hydrochloride Fludarabine Citalopram Losmapimod Iopromide More therapies…

    Learn about Your Condition

    Nervous system disorder Hypersomnia Pituitary tumour benign Liposarcoma Malignant glioma Alport's syndrome Myopia Urinary incontinence Renal disorder Gestational diabetes Colorectal cancer stage IV Mesothelioma Vaginal cancer Anal cancer Angiopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Frontotemporal dementia

  • Study on the Safety and Effects of DNL593 for Patients with Frontotemporal Dementia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Frontotemporal dementia
    Investigated Drugs:
    • DNL593
    • Famotidine
    Belgium Czechia France Italy The Netherlands Portugal +1

  • Study on the Accuracy of Tau PET ([18F]RO6958948) and Vizamyl (Flutemetamol 18F) in Diagnosing Mild Cognitive Symptoms and Risk of Alzheimer’s Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Progressive supranuclear palsy
    • Dementia with Lewy bodies
    • Prodromal Alzheimer’s disease
    Investigated Drugs:
    • 2-(6-[18F]Fluoro-Pyridin-3-Yl)-9H-Dipyrido[2,3-B:3′,4′-D]Pyrrole
    • Flutemetamol (18F)
    Sweden

  • Study on AVB-101 for Patients with Frontotemporal Dementia with Progranulin Mutations

    Recruiting

    2 1 1
    Investigated Diseases:
    • Frontotemporal dementia
    Investigated Drugs:
    • Avb-101
    Belgium Italy The Netherlands Poland Spain Sweden

  • Study on the Safety and Effects of LY3884963 for Patients with Fronto-Temporal Dementia with Progranulin Mutations

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Frontotemporal dementia
    Investigated Drugs:
    • Adeno-Associated Viral Vector Serotype 9 Expressing Codon-Optimized Human Grn Gene
    • Methylprednisolone
    • Prednisone
    Belgium France

  • Study on the Effects of Latozinemab for Patients with Frontotemporal Dementia Due to Progranulin Gene Mutations

    Not recruiting

    3 1
    Investigated Diseases:
    • Frontotemporal dementia
    Investigated Drugs:
    • Latozinemab
    Belgium France Germany Greece Italy The Netherlands +3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!